Veradermics, Inc MANE
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2026-02-04
Veradermics, Inc statistics & valuation
Market cap$5.3B
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -45.9% | -47.7% |
| Return on equity | 57.8% | 54.6% |
| Current ratio | 16.66 | 11.77 |
Source: SEC EDGAR filings · CIK 0001827635 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.